Form 4: CG Oncology Director Hong Fang Song Sells Shares in Recent Transaction

Director Hong Fang Song reports the sale of CG Oncology (CGON) shares held indirectly through investment entities.

Summary

• Hong Fang Song, a director of CG Oncology, filed a Form 4 detailing changes in beneficial ownership.
• On August 29, 2024, Song sold 424,210 shares of Common Stock at a price of $35.36 per share.
• On August 29, 2024, Song sold 226,245 shares of Common Stock at a price of $35.36 per share.
• The shares were held indirectly through Unique Diamond Investments Limited and Charming Jade Limited.
• Following the transactions, Song continues to beneficially own 586,982 shares through Unique Diamond Investments Limited and 3,703,931 shares through Charming Jade Limited, as well as 613,928 shares directly.
• Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock sales by a company director. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, although the director still holds a significant number of shares.

Key Dates